Detalhe da pesquisa
1.
Performance of magnetic resonance imaging-based prostate cancer risk calculators and decision strategies in two large European medical centres.
BJU Int
; 133(3): 278-288, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37607322
2.
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).
BJU Int
; 133(6): 680-689, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469686
3.
Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy.
NMR Biomed
; 36(5): e4694, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032074
4.
The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics features.
MAGMA
; 36(6): 945-956, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556085
5.
Pseudo-T2 mapping for normalization of T2-weighted prostate MRI.
MAGMA
; 35(4): 573-585, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150363
6.
Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue.
Anal Chem
; 92(4): 3171-3179, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31944670
7.
Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential.
J Magn Reson Imaging
; 51(6): 1900-1910, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31794113
8.
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
Br J Cancer
; 118(6): e11, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462127
9.
Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis.
Magn Reson Med
; 79(5): 2524-2532, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862352
10.
Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized.
BMC Cancer
; 18(1): 478, 2018 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703166
11.
18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients.
Eur Radiol
; 28(8): 3151-3159, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29294158
12.
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
Br J Cancer
; 117(11): 1656-1664, 2017 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972967
13.
A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer.
Eur J Nucl Med Mol Imaging
; 44(4): 695-703, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27817158
14.
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
J Transl Med
; 14: 71, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975394
15.
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.
Br J Cancer
; 113(12): 1712-9, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26633561
16.
Identification of metabolites from 2D (1)H-(13)C HSQC NMR using peak correlation plots.
BMC Bioinformatics
; 15: 413, 2014 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25511422
17.
Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.
BMC Urol
; 14: 49, 2014 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24929427
18.
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score.
NMR Biomed
; 26(5): 600-6, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23280546
19.
Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification.
BJUI Compass
; 3(5): 344-353, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950035
20.
The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems.
iScience
; 25(6): 104451, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35707723